Lupus
This research study is investigating a new oral medication that provides another way of treating CLE. The goal of the study is to understand if the drug can safely reduce skin symptoms associated with CLE.
Participation lasts up to 18 weeks, which includes screening, a treatment period, and follow-up visits. Because this is a randomized study, neither participants nor the study team will know who receives the study drug or a placebo.
Participants will receive study-related medical care throughout the study, and will receive compensation for their time and efforts. Travel reimbursement may be available as well.
Take the survey to find out if you may be eligible to participate.
Why Lupus Research Matters
Lupus is an autoimmune condition. This means the immune system becomes overactive and can attack healthy tissue.
In cutaneous lupus, the immune system primarily attacks the skin. Symptoms may include: rashes or skin lesions; red, scaly, or thickened areas of skin; skin sensitivity or discomfort; changes in skin color or scarring.
Some people with cutaneous lupus also have systemic lupus, which can affect other parts of the body such as the joints, kidneys, lungs, heart, eyes, or brain.
This study focuses on skin symptoms of lupus, whether or not other organs are affected.
Click on Take the Survey below to learn more.
Lupus is an autoimmune condition. This means the immune system becomes overactive and can attack healthy tissue. In cutaneous lupus, the immune system primarily affects the skin. Symptoms may include: rashes or skin lesions; red, scaly, or thickened areas of skin; skin sensitivity or discomfort; changes in skin color or scarring.
Some people with cutaneous lupus also have systemic lupus, which can affect other parts of the body such as the joints, kidneys, lungs, heart, eyes, or brain. This study focuses on skin symptoms of lupus, whether or not other organs are affected. Helping resarchers better understand lupus and how it affects the whole body may mean more effective treatment options in the future.
Helping resarchers better understand lupus and how it affects the whole body may mean more effective treatment options in the future.
Eligibility Requirements
You may be able to participate if you:
Are between 18 and 80 years old with active cutaneous lupus
Have lupus-related skin symptoms on any part of your body. If symptoms occur on your face, they must also be present on other areas of the body to be eligible.
Are interested in participating in clinical research
Click the button below to take the survey and find out right away if you prequalify.
Take the Survey
